A Phase 1, Open-Label, Fixed Sequence Study to Investigate the Effect of Itraconazole on the Pharmacokinetics of Debio 1450 in Healthy Subjects

Trial Profile

A Phase 1, Open-Label, Fixed Sequence Study to Investigate the Effect of Itraconazole on the Pharmacokinetics of Debio 1450 in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Sep 2017

At a glance

  • Drugs Afabicin (Primary) ; Itraconazole
  • Indications Bone and joint infections; Skin and soft tissue infections
  • Focus Pharmacokinetics
  • Sponsors Debiopharm
  • Most Recent Events

    • 22 Sep 2017 Status changed from active, no longer recruiting to completed.
    • 21 Aug 2017 Planned End Date changed from 25 Oct 2017 to 1 Aug 2017.
    • 21 Aug 2017 Planned primary completion date changed from 3 Oct 2017 to 1 Aug 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top